Company profile for Opus Genetics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need wit...
Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
37000 Grand River Avenue, Suite 120, Farmington Hills, MI 48335
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/16/3206594/0/en/Opus-Genetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
16 Dec 2025

https://www.globenewswire.com/news-release/2025/12/11/3203756/0/en/Opus-Genetics-to-Present-at-the-J-P-Morgan-2026-Healthcare-Conference.html

GLOBENEWSWIRE
11 Dec 2025

https://www.globenewswire.com/news-release/2025/11/20/3191855/0/en/Opus-Genetics-to-Participate-in-Upcoming-Investment-Conferences.html

GLOBENEWSWIRE
20 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187171/0/en/Opus-Genetics-Announces-Dosing-of-First-Participant-in-OPGx-BEST1-Phase-1-2-Gene-Therapy-Clinical-Trial-for-Best-Disease.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180818/0/en/Opus-Genetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179205/0/en/Opus-Genetics-Featured-on-Good-Morning-America-Spotlighting-Breakthrough-Gene-Therapy-Restoring-Sight-in-Patients-with-Inherited-Blindness.html

GLOBENEWSWIRE
03 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty